RxDoctor Payments DataLook up a doctor →

Michael Bentley, MD

Plastic and Reconstructive Surgery · Montgomery, ALNPI 1063472322

Payments from drug & device makers

$267,100in general payments, 2019–2025

Across 707 payments — averaging $377.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$245K
  • Medical Device Business Services, Inc.$17K
  • AbbVie$4K
  • Merz North America, Inc.$467
  • Sientra, Inc.$205
  • Integra Lifesciences Corporation$183
  • plus $324 from 11 others

What the payments were for

  • Food & beverage$5,37199%
  • Education$291%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$267,100 in reported general payments places this provider in the 95th percentile of 35 plastic and reconstructive surgery providers in Alabama.

See all plastic and reconstructive surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$5,517
Medicare patients
12
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin33$349
ErythromycinErythromycin Base26$289
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$177
Ondansetron Hcl22$175
Diazepam11$44

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →